glp 3 tirzepatide 1 lr3 Beyond GLP-1: Retatrutide's triple-agonist mechanism (GLP-1, GIP, glucagon) is redefining metabolic health. Phase 2 data shows ~24% weight loss—surpassing semaglutide & tirzepatide. Evidence-based protocols demand nutrition support alongside Tirzepatide | GLP-1R and GIPR

Overweight and obesity as determinants of cardiovascular risk: the Framingham experience

RNA could now be rapidly isolated from intestinal cells, transcribed into recombinant cDNA and then cloned into a circular DNA plasmid

Citizen Meds has been incredible

Abstract Purpose Chronic kidney disease (CKD) is one of the most common complications of type 2 diabetes (T2D), and CKD-related disability and mortality are increasing despite the recent advances in diabetes management

Acetyl-L-carnitine (ALCAR) for the prevention of chemotherapy-induced peripheral neuropathy in patients with relapsed or refractory multiple myeloma treated with bortezomib, doxorubicin and low-dose dexamethasone: a study from the wisconsin oncology network